RecruitingNCT06414785

Characterization of Capsule Inflammation in Patients Exposed to Silicone Breast Implants

Studying NLRP3-associated autoinflammatory disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire de Besancon
Principal Investigator
Isabelle PLUVY
CHU de Besançon
Intervention
analysis of samples of periprosthetic capsules taken during breast implant change procedure(other)
Enrollment
100 target
Eligibility
18-99 years · FEMALE
Timeline
20242025

Study locations (1)

Collaborators

Institut de Science des Matériaux de Mulhouse IS2M · NOVOTEC labs (lyon)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06414785 on ClinicalTrials.gov

Other trials for NLRP3-associated autoinflammatory disease

Additional recruiting or active studies for the same condition.

See all trials for NLRP3-associated autoinflammatory disease

← Back to all trials